Vilalta-Franch J

References (9)

Title : Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer's disease: a cumulative meta-analysis and trial sequential analysis - Blanco-Silvente_2019_Eur.J.Clin.Pharmacol_75_1659
Author(s) : Blanco-Silvente L , Castells X , Garre-Olmo J , Vilalta-Franch J , Saez M , Barcelo MA , Capella D
Ref : European Journal of Clinical Pharmacology , 75 :1659 , 2019
Abstract : Blanco-Silvente_2019_Eur.J.Clin.Pharmacol_75_1659
ESTHER : Blanco-Silvente_2019_Eur.J.Clin.Pharmacol_75_1659
PubMedSearch : Blanco-Silvente_2019_Eur.J.Clin.Pharmacol_75_1659
PubMedID: 31435707

Title : Trends in the Prescription and Long-Term Utilization of Antidementia Drugs Among Patients with Alzheimer's Disease in Spain: A Cohort Study Using the Registry of Dementias of Girona - Calvo-Perxas_2017_Drugs.Aging_34_303
Author(s) : Calvo-Perxas L , Turro-Garriga O , Vilalta-Franch J , Lozano-Gallego M , de Eugenio R , Marquez F , Carmona O , Gich J , Manzano A , Vinas M , Roig AM , Garre-Olmo J
Ref : Drugs & Aging , 34 :303 , 2017
Abstract : Calvo-Perxas_2017_Drugs.Aging_34_303
ESTHER : Calvo-Perxas_2017_Drugs.Aging_34_303
PubMedSearch : Calvo-Perxas_2017_Drugs.Aging_34_303
PubMedID: 28258538

Title : Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients - Blanco-Silvente_2017_Int.J.Neuropsychopharmacol_20_519
Author(s) : Blanco-Silvente L , Castells X , Saez M , Barcelo MA , Garre-Olmo J , Vilalta-Franch J , Capella D
Ref : Int J Neuropsychopharmacol , 20 :519 , 2017
Abstract : Blanco-Silvente_2017_Int.J.Neuropsychopharmacol_20_519
ESTHER : Blanco-Silvente_2017_Int.J.Neuropsychopharmacol_20_519
PubMedSearch : Blanco-Silvente_2017_Int.J.Neuropsychopharmacol_20_519
PubMedID: 28201726

Title : [Cognitive decline in Alzheimer's disease. A follow three or more years of a sample of patients] - Conde-Sala_2013_Rev.Neurol_56_593
Author(s) : Conde-Sala JL , Garre-Olmo J , Vilalta-Franch J , Llinas-Regla J , Turro-Garriga O , Lozano-Gallego M , Hernandez-Ferrandiz M , Pericot-Nierga I , Lopez-Pousa S
Ref : Rev Neurol , 56 :593 , 2013
Abstract : Conde-Sala_2013_Rev.Neurol_56_593
ESTHER : Conde-Sala_2013_Rev.Neurol_56_593
PubMedSearch : Conde-Sala_2013_Rev.Neurol_56_593
PubMedID: 23744245

Title : Use of antidementia drugs in frontotemporal lobar degeneration - Lopez-Pousa_2012_Am.J.Alzheimers.Dis.Other.Demen_27_260
Author(s) : Lopez-Pousa S , Calvo-Perxas L , Lejarreta S , Cullell M , Melendez R , Hernandez E , Bisbe J , Perkal H , Manzano A , Roig AM , Turro-Garriga O , Vilalta-Franch J , Garre-Olmo J
Ref : Am J Alzheimers Dis Other Demen , 27 :260 , 2012
Abstract : Lopez-Pousa_2012_Am.J.Alzheimers.Dis.Other.Demen_27_260
ESTHER : Lopez-Pousa_2012_Am.J.Alzheimers.Dis.Other.Demen_27_260
PubMedSearch : Lopez-Pousa_2012_Am.J.Alzheimers.Dis.Other.Demen_27_260
PubMedID: 22605780

Title : Consumption of pharmaceuticals in primary non-Alzheimer's degenerative dementias : a cross-sectional study by the Registry of Dementias of Girona (ReDeGi) - Lopez-Pousa_2012_Drugs.Aging_29_733
Author(s) : Lopez-Pousa S , Turro-Garriga O , Calvo-Perxas L , Carmona O , Gich J , Alsina E , Marquez F , Vinas M , Turbau J , Vilalta-Franch J , Roig AM , Garre-Olmo J
Ref : Drugs & Aging , 29 :733 , 2012
Abstract : Lopez-Pousa_2012_Drugs.Aging_29_733
ESTHER : Lopez-Pousa_2012_Drugs.Aging_29_733
PubMedSearch : Lopez-Pousa_2012_Drugs.Aging_29_733
PubMedID: 23018609

Title : [Metabolic syndrome in Alzheimer's disease: clinical and developmental influences] - Vilalta-Franch_2008_Rev.Neurol_46_13
Author(s) : Vilalta-Franch J , Lopez-Pousa S , Garre-Olmo J , Turon-Estrada A , Pericot-Nierga I
Ref : Rev Neurol , 46 :13 , 2008
Abstract : Vilalta-Franch_2008_Rev.Neurol_46_13
ESTHER : Vilalta-Franch_2008_Rev.Neurol_46_13
PubMedSearch : Vilalta-Franch_2008_Rev.Neurol_46_13
PubMedID: 18214821

Title : [Mortality rates in patients with Alzheimer's disease treated with atypical neuroleptic drugs] - Vilalta-Franch_2008_Rev.Neurol_46_129
Author(s) : Vilalta-Franch J , Lopez-Pousa S , Garre-Olmo J , Turon-Estrada A , Pericot-Nierga I
Ref : Rev Neurol , 46 :129 , 2008
Abstract : Vilalta-Franch_2008_Rev.Neurol_46_129
ESTHER : Vilalta-Franch_2008_Rev.Neurol_46_129
PubMedSearch : Vilalta-Franch_2008_Rev.Neurol_46_129
PubMedID: 18297617

Title : [Treatment for non-cognitive symptoms in Alzheimer's disease] - Vilalta-Franch_1999_Rev.Neurol_29_819
Author(s) : Vilalta-Franch J , Lopez-Pousa S , Llinas-Regla J
Ref : Rev Neurol , 29 :819 , 1999
Abstract : Vilalta-Franch_1999_Rev.Neurol_29_819
ESTHER : Vilalta-Franch_1999_Rev.Neurol_29_819
PubMedSearch : Vilalta-Franch_1999_Rev.Neurol_29_819
PubMedID: 10696656